Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats

Fig. 1

Mean respiratory frequency of the cats per study group as of the day (SD 83) prior to experimental infection with L3 of Aelurostrongylus abstrusus. G1: treatment 12 weeks before experimental infection, G2: treatment 8 weeks before experimental infection, G3: treatment 4 weeks before experimental infection, G4: control group

Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us